NCT00675740View on ClinicalTrials.gov

Physical Exercise Versus Rosiglitazone in CAD and Prediabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Impaired Glucose Tolerance
Interventions
DRUG

rosiglitazone

tablets 4 mg daily

BEHAVIORAL

physical exercise

stationary bike 5-6 times a week

OTHER

control

control without intervention

All Listed Sponsors
lead

University of Leipzig

OTHER

NCT00675740 - Physical Exercise Versus Rosiglitazone in CAD and Prediabetes | Biotech Hunter | Biotech Hunter